Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Anaemia megaloblastic | x | ||
Angioedema | x | ||
Anxiety | x | ||
Apnoea | x | ||
Ataxia | x | ||
Confusional state | x | ||
Constipation | x | ||
Dermatitis exfoliative | x | ||
Dizziness | x | ||
Rash | x | ||
Body temperature increased | x | ||
Hallucination | x | ||
Headache | x | ||
Hypersensitivity | x | ||
Hypotension | x | ||
Nausea | x | ||
Nervousness | x | ||
Nightmare | x | ||
Syncope | x | ||
Vomiting | x | ||
Agitation | x | ||
CNS depression NOS | x | ||
Injection site reaction | x | ||
Hepatocellular injury | x | ||
Hyperkinesia | x | ||
Bradycardia | x | ||
Somnolence | x | ||
Hypoventilation | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||
---|---|---|---|
Cholera | x | ||
Eclampsia | x | ||
Insomnia | x | ||
Meningitis | x | ||
Status epilepticus | x | ||
Tetanus | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |